As artificial intelligence (AI) continues to revolutionize the economy, courts are increasingly being asked to determine whether AI models and algorithms can be protected as trade secrets. Yet case ...

The Working Group on Access to Medicines and Treatment, India, has alleged that the Central government is considering to introduce data exclusivity (DE) provisions into India’s drug regulatory laws ...

Order likely to affect U.S. chipmakers Nvidia, AMD, Intel Beijing trying to cultivate domestic AI chipmakers like Huawei U.S. has tried to use AI chips as leverage in China trade talks China and the U ...

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines. Dr. Reddy’s, an Indian generic ...

A now patched flaw in Microsoft 365 Copilot let attackers turn its diagram tool, Mermaid, into a data exfiltration channel–fetching and encoding emails through hidden instructions in Office documents.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

TL;DR: Get a lifetime license to Microsoft Visio Professional 2021 for Windows for just $14.97 (MSRP $249.99) and bring clarity to complex data with powerful templates, shapes, and collaboration tools ...

Before government shutdowns end, political blame games begin. And as politicians from both parties try to blame each other, party operatives and pundits scour the poll data to see who wins the game.

Share on Pinterest The FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty Images The approval, ...

Nearly every Republican senator signed a letter Thursday urging the Food and Drug Administration (FDA) to reverse its decision to approve a “generic” version of the abortion pill mifepristone, which ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

WASHINGTON — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians ...